CHU
CHU
Nantes, France2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Multi-center Open-label Phase 2 Study of Ixazomib, Iberdomide and Dexamethasone in Elderly Patients With Multiple Myeloma at First Relapse." | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 2 | 2026-06-15 | NCT04998786 | |
| Brain-injured Patients Extubation Readiness Study | Brain Injuries, Traumatic, Coma, Consciousness Disorders, Consciousness, Level Altered, Craniocerebral Trauma, Hypoxia, Hypoxia, Brain, Injuries, Acute Brain, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, Unconsciousness, brain disorder, brain hypoxia - ischemia, brain injury, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, injury, nervous system disorder, nervous system injury, psychiatric disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2025-09-24 | NCT04080440 |